Berhanu et al., Cancer Res 2006
(Neoplasms, Experimental) :
Combinational FLt3 ligand and granulocyte macrophage colony stimulating factor treatment promotes enhanced tumor infiltration by dendritic cells and antitumor CD8 ( + ) T-cell cross priming but is ineffective as a therapy
Kashiwada et al., Blood 2011
:
Flt3 ligand dependent generation of CD8a ( + ) cDCs in lymphoid tissues and CD8a ( + ) -equivalent cDCs from Nfil3 ( -/- ) bone marrow cells was also impaired